GLP-1 Price Check
Our pricing methodology accounts for mandatory fees and four-week billing. Use the GLP-1 cost calculator to turn a quote with separate fees or a prepaid term into a monthly amount. Enter that amount below to see where it falls among 345 published prices.
Against 158 published prices for semaglutide, injection
$249 a month is higher than 80% of them. The median is $186, and the published range runs $60 to $1299.
123 published prices are lower. Against the median you would pay $756 more across a year.
What this number is not
- Cheaper is not better. Some of the lowest figures here are microdoses, which are a smaller dose rather than a discount on the same product, and some are opening prices that rise at the next step of the ladder.
- Every figure is all-in as far as we can establish it. Where a seller charges a membership or a program fee outside its headline, we add it before ranking. Your quote may not be on the same basis — check what it excludes before comparing.
- A month must be a month. Several sellers price a four-week supply and print it with a monthly symbol. Thirteen of those land in a year, not twelve.
- These are advertised prices, not walked checkouts. They are what each seller publishes, corrected for fees and terms — not what a completed purchase charged.
Why a median is more useful here than a lowest price
Injectable semaglutide runs from $60 to $1299 a month across 158 sellers, and the median sits at $186. That gives you a benchmark for a quote. Two prices in the same range can cover different doses, formulations or services.
A low opening price may cover a smaller dose or apply only to the first fill. The dose pricing comparison shows which sellers say their regular rate changes at higher doses. Check which dose the quote covers before using the median as a benchmark.
The comparison uses sellers’ published prices, adjusted for known fees and billing terms. The price freshness table shows when semaglutide injection prices were last checked. Confirm the current amount with the provider before paying.
Most products in the tool are compounded. The FDA does not approve compounded drugs or review them for safety, effectiveness or quality before dispensing.